Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-036569
Filing Date
2022-03-22
Accepted
2022-03-22 16:15:17
Documents
1
Group Members
AARON GLENN LOUIS FLETCHERBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS EQUITY PARTNERS II, LPBIOS FUND I QP, LPBIOS FUND I, LPBIOS FUND II NT, LPBIOS FUND II QP, LPBIOS FUND II, LPBP DIRECTORS, LPCAVU ADVISORS, LLCCAVU MANAGEMENT, LPLESLIE WAYNE K

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm229824d1_sc13da.htm SC 13D/A 320228
  Complete submission text file 0001104659-22-036569.txt   322287
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91536 | Film No.: 22759680
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-381-5370
Bios Equity Partners, LP (Filed by) CIK: 0001813314 (see all company filings)

EIN.: 822422973 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A